Literature DB >> 33411248

Increasing Nrf2 Activity as a Treatment Approach in Neuropsychiatry.

G Morris1, A J Walker1, K Walder1, M Berk1,2,3, W Marx1, A F Carvalho4,5, M Maes1,6, B K Puri7.   

Abstract

Nuclear factor erythroid 2-related factor 2 (Nrf2) is a transcription factor encoded by NFE2L2. Under oxidative stress, Nrf2 does not undergo its normal cytoplasmic degradation but instead travels to the nucleus, where it binds to a DNA promoter and initiates transcription of anti-oxidative genes. Nrf2 upregulation is associated with increased cellular levels of glutathione disulfide, glutathione peroxidase, glutathione transferases, thioredoxin and thioredoxin reductase. Given its key role in governing the cellular antioxidant response, upregulation of Nrf2 has been suggested as a common therapeutic target in neuropsychiatric illnesses such as major depressive disorder, bipolar disorder and schizophrenia, which are associated with chronic oxidative and nitrosative stress, characterised by elevated levels of reactive oxygen species, nitric oxide and peroxynitrite. These processes lead to extensive lipid peroxidation, protein oxidation and carbonylation, and oxidative damage to nuclear and mitochondrial DNA. Intake of N-acetylcysteine, coenzyme Q10 and melatonin is accompanied by increased Nrf2 activity. N-acetylcysteine intake is associated with improved cerebral mitochondrial function, decreased central oxidative and nitrosative stress, reduced neuroinflammation, alleviation of endoplasmic reticular stress and suppression of the unfolded protein response. Coenzyme Q10, which acts as a superoxide scavenger in neuroglial mitochondria, instigates mitohormesis, ameliorates lipid peroxidation in the inner mitochondrial membrane, activates uncoupling proteins, promotes mitochondrial biogenesis and has positive effects on the plasma membrane redox system. Melatonin, which scavenges mitochondrial free radicals, inhibits mitochondrial nitric oxide synthase, restores mitochondrial calcium homeostasis, deacetylates and activates mitochondrial SIRT3, ameliorates increased permeability of the blood-brain barrier and intestine and counters neuroinflammation and glutamate excitotoxicity.

Entities:  

Keywords:  Coenzyme Q10; Melatonin; Molecular neurobiology; N-acetylcysteine; Nrf2; Oxidative stress

Year:  2021        PMID: 33411248     DOI: 10.1007/s12035-020-02212-w

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  296 in total

Review 1.  A model of the mitochondrial basis of bipolar disorder.

Authors:  Gerwyn Morris; Ken Walder; Sean L McGee; Olivia M Dean; Susannah J Tye; Michael Maes; Michael Berk
Journal:  Neurosci Biobehav Rev       Date:  2017-01-14       Impact factor: 8.989

Review 2.  Mitochondrial dysfunction in schizophrenia: pathways, mechanisms and implications.

Authors:  Ashwini Rajasekaran; Ganesan Venkatasubramanian; Michael Berk; Monojit Debnath
Journal:  Neurosci Biobehav Rev       Date:  2014-11-15       Impact factor: 8.989

Review 3.  Mitochondrial dysfunction in bipolar disorder: Evidence, pathophysiology and translational implications.

Authors:  Giselli Scaini; Gislaine T Rezin; Andre F Carvalho; Emilio L Streck; Michael Berk; João Quevedo
Journal:  Neurosci Biobehav Rev       Date:  2016-07-01       Impact factor: 8.989

4.  Glutamate metabolism in major depressive disorder.

Authors:  Chadi G Abdallah; Lihong Jiang; Henk M De Feyter; Madonna Fasula; John H Krystal; Douglas L Rothman; Graeme F Mason; Gerard Sanacora
Journal:  Am J Psychiatry       Date:  2014-10-31       Impact factor: 18.112

Review 5.  Mitochondrial Dysfunction in Depression.

Authors:  Yashika Bansal; Anurag Kuhad
Journal:  Curr Neuropharmacol       Date:  2016       Impact factor: 7.363

6.  Cerebrospinal fluid metabolomics identifies a key role of isocitrate dehydrogenase in bipolar disorder: evidence in support of mitochondrial dysfunction hypothesis.

Authors:  N Yoshimi; T Futamura; S E Bergen; Y Iwayama; T Ishima; C Sellgren; C J Ekman; J Jakobsson; E Pålsson; K Kakumoto; Y Ohgi; T Yoshikawa; M Landén; K Hashimoto
Journal:  Mol Psychiatry       Date:  2016-01-19       Impact factor: 15.992

Review 7.  The Energy Metabolism Dysfunction in Psychiatric Disorders Postmortem Brains: Focus on Proteomic Evidence.

Authors:  Giuliana S Zuccoli; Verônica M Saia-Cereda; Juliana M Nascimento; Daniel Martins-de-Souza
Journal:  Front Neurosci       Date:  2017-09-07       Impact factor: 4.677

Review 8.  Molecular Mechanisms of Bipolar Disorder: Progress Made and Future Challenges.

Authors:  Yeni Kim; Renata Santos; Fred H Gage; Maria C Marchetto
Journal:  Front Cell Neurosci       Date:  2017-02-14       Impact factor: 5.505

Review 9.  Mitochondria and Mood: Mitochondrial Dysfunction as a Key Player in the Manifestation of Depression.

Authors:  Josh Allen; Raquel Romay-Tallon; Kyle J Brymer; Hector J Caruncho; Lisa E Kalynchuk
Journal:  Front Neurosci       Date:  2018-06-06       Impact factor: 4.677

Review 10.  Is There a Role of Autophagy in Depression and Antidepressant Action?

Authors:  Nils C Gassen; Theo Rein
Journal:  Front Psychiatry       Date:  2019-05-15       Impact factor: 4.157

View more
  6 in total

Review 1.  The Molecular Mechanisms of Ferroptosis and Its Role in Blood-Brain Barrier Dysfunction.

Authors:  Xiaoshu Chen; Xinru Pang; Abrey J Yeo; Siwen Xie; Mengting Xiang; Bin Shi; Gongchang Yu; Chao Li
Journal:  Front Cell Neurosci       Date:  2022-05-19       Impact factor: 6.147

Review 2.  Melatonin and multiple sclerosis: antioxidant, anti-inflammatory and immunomodulator mechanism of action.

Authors:  Ana Muñoz-Jurado; Begoña M Escribano; Javier Caballero-Villarraso; Alberto Galván; Eduardo Agüera; Abel Santamaría; Isaac Túnez
Journal:  Inflammopharmacology       Date:  2022-06-05       Impact factor: 5.093

3.  Dietary Selenium Alleviated Mouse Liver Oxidative Stress and NAFLD Induced by Obesity by Regulating the KEAP1/NRF2 Pathway.

Authors:  Yi Wang; Bingbing Liu; Peixuan Wu; Yi Chu; Sisi Gui; Yazhen Zheng; Xiaodong Chen
Journal:  Antioxidants (Basel)       Date:  2022-02-10

4.  Polysaccharides from Polygonatum cyrtonema Hua Reduce Depression-Like Behavior in Mice by Inhibiting Oxidative Stress-Calpain-1-NLRP3 Signaling Axis.

Authors:  Fengming Shen; Pan Xie; Congting Li; Zhijuan Bian; Xuncui Wang; Daiyin Peng; Guoqi Zhu
Journal:  Oxid Med Cell Longev       Date:  2022-04-20       Impact factor: 7.310

Review 5.  The Role of G Protein-Coupled Receptors (GPCRs) and Calcium Signaling in Schizophrenia. Focus on GPCRs Activated by Neurotransmitters and Chemokines.

Authors:  Tomasz Boczek; Joanna Mackiewicz; Marta Sobolczyk; Julia Wawrzyniak; Malwina Lisek; Bozena Ferenc; Feng Guo; Ludmila Zylinska
Journal:  Cells       Date:  2021-05-17       Impact factor: 6.600

6.  Antioxidant and Neuroprotective Activity of Extra Virgin Olive Oil Extracts Obtained from Quercetano Cultivar Trees Grown in Different Areas of the Tuscany Region (Italy).

Authors:  Maria Cristina Barbalace; Lorenzo Zallocco; Daniela Beghelli; Maurizio Ronci; Serena Scortichini; Maria Digiacomo; Marco Macchia; Maria Rosa Mazzoni; Dennis Fiorini; Antonio Lucacchini; Silvana Hrelia; Laura Giusti; Cristina Angeloni
Journal:  Antioxidants (Basel)       Date:  2021-03-10
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.